Showing results (411-420 of 601) with videos related to

Sort By:
Pageof 61
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2001
Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patientsD N Reddan, R J Marcus, W F Owen, et al.
Kidney International|May 3, 2000
Evidence for genetic factors in the development and progression of IgA nephropathyS I Hsu, S B Ramirez, M P Winn, et al.
Experimental Physiology|July 2, 2026
Thermal and cardiovascular responses to sauna are attenuated by adding cold water immersion to cooling breaksTomos F Owen, Callum J Giles, Samuel F Leaney, et al.
Biological Reviews of the Cambridge Philosophical Society|May 12, 2025
Critical insights into the potential risks of antipsychotic drugs to fish, including through effects on behaviourGabrielle Wasser-Bennett, A Ross Brown, Samuel K Maynard, et al.
Kidney International|November 13, 2001
Association between prevalent care process measures and facility-specific mortality ratesE G Lowrie, M Teng, E Lacson, et al.
Neuroscience Letters|September 1, 2009
Loss of otolith function with age is associated with increased postural sway measuresJorge M Serrador, Lewis A Lipsitz, Gosala S Gopalakrishnan, et al.
The Journal of Hand Surgery, European Volume|July 2, 2011
Rheumatoid hand surgery: differing perceptions amongst surgeons, rheumatologists and therapists in the UKF D Burke, S M Miranda, V M F Owen, et al.
American Heart Journal|August 17, 2004
Slowing the progression of diabetic nephropathy and its cardiovascular consequencesPeter A McCullough, George L Bakris, William F Owen, et al.
Brain Research|December 12, 1983
Peptides, the limbic lobe and schizophreniaG W Roberts, I N Ferrier, Y Lee, et al.
Life Sciences|August 1, 1983
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophreniaI N Ferrier, G W Roberts, T J Crow, et al.
Pageof 61